PRAME-AS and neoplasm: These findings suggest that the regulatory axis involving PRAME-AS, MZF1, and epigenetic elements such as CpG islands plays a pivotal role in PRAME regulation in cancers, highlighting PRAME-AS as a potential key contributor to tumor processes.